Moreover, Bcl-2 is suggested as a potential therapeutic target for AD since the overexpression of Bcl-2 in a transgenic AD mouse model suppressed the formation of plaques and neurofibrillary tangles and improved memory retention [193]. Here, BCL2 is linked to Alzheimer disease.